TNFRSF8/CD30 Antibody (MMAE)

• Catalog Number: orb1805473
• Category: Antibodies
• Description: Anti-TNFRSF8 / CD30 Reference Antibody and Monomethyl auristatin E (MMAE) that inhibits CD30-positive cells and is used for the study of relapsed and refractory Hogkin's lymphoma.
• Target: TNFRSF8 / CD30
• Clonality: Recombinant
• Conjugation: MMAE
• Reactivity: Human
• Concentration: Batch dependent
• Buffer/Preservatives: 100 mM Proline/Acetic acid 20mM Arginine pH 5.0
• Purity: >95%
• Purification: Protein A
• UniProt ID: P28908
• MW: 145.48 kDa
• Tested applications: ELISA, FA, FACS, In vivo
• Antibody Type: Recombinant Antibody
• Expression System: CHO
• Endotoxins: <0.001 EU/ug
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Note: For research use only

Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin)is more than 98.99% ;determined by SEC-HPLC.

Immobilized human CD30 His at 2 μg/mL can bind Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin);EC50=0.006007μg/mL.